Image of Gail H Cassell

Gail H Cassell, Ph.D.

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease.
Authors: Authors: Hardy RD, Jafri HS, Olsen K, Hatfield J, Iglehart J, Rogers BB, Patel P, Cassell G, McCracken GH, Ramilo O.
Infect Immun
View full abstract on Pubmed
Lung pathology in premature infants with Ureaplasma urealyticum infection.
Authors: Authors: Viscardi RM, Manimtim WM, Sun CC, Duffy L, Cassell GH.
Pediatr Dev Pathol
View full abstract on Pubmed
Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth.
Authors: Authors: Lu GC, Schwebke JR, Duffy LB, Cassell GH, Hauth JC, Andrews WW, Goldenberg RL.
Am J Obstet Gynecol
View full abstract on Pubmed
Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile.
Authors: Authors: Hardy RD, Jafri HS, Olsen K, Wordemann M, Hatfield J, Rogers BB, Patel P, Duffy L, Cassell G, McCracken GH, Ramilo O.
Infect Immun
View full abstract on Pubmed
A link between chronic asthma and chronic infection.
Authors: Authors: Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH.
J Allergy Clin Immunol
View full abstract on Pubmed
Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance.
Authors: Authors: Cassell GH, Mekalanos J.
JAMA
View full abstract on Pubmed
The complete sequence of the mucosal pathogen Ureaplasma urealyticum.
Authors: Authors: Glass JI, Lefkowitz EJ, Glass JS, Heiner CR, Chen EY, Cassell GH.
Nature
View full abstract on Pubmed
Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases.
Authors: Authors: Klemm M, Cheng C, Cassell G, Shuman S, Segall AM.
J Mol Biol
View full abstract on Pubmed
Antibody responses after Sendai virus infection and their role in upper and lower respiratory tract disease in rats.
Authors: Authors: Liang SC, Simecka JW, Lindsey JR, Cassell GH, Davis JK.
Lab Anim Sci
View full abstract on Pubmed
Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome.
Authors: Authors: Yáñez A, Cedillo L, Neyrolles O, Alonso E, Prévost MC, Rojas J, Watson HL, Blanchard A, Cassell GH.
Emerg Infect Dis
View full abstract on Pubmed